Does FOSPHENYTOIN Cause Disease recurrence? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Disease recurrence have been filed in association with FOSPHENYTOIN (CEREBYX). This represents 0.5% of all adverse event reports for FOSPHENYTOIN.
7
Reports of Disease recurrence with FOSPHENYTOIN
0.5%
of all FOSPHENYTOIN reports
0
Deaths
4
Hospitalizations
How Dangerous Is Disease recurrence From FOSPHENYTOIN?
Of the 7 reports, 4 (57.1%) required hospitalization, and 3 (42.9%) were considered life-threatening.
Is Disease recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSPHENYTOIN. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does FOSPHENYTOIN Cause?
Drug ineffective (406)
Off label use (164)
Status epilepticus (82)
Multiple-drug resistance (77)
Cardiac arrest (72)
Seizure (70)
Drug ineffective for unapproved indication (63)
Hypotension (56)
Toxicity to various agents (53)
Bradycardia (39)
What Other Drugs Cause Disease recurrence?
NIRMATRELVIR\RITONAVIR (20,040)
PREDNISONE (1,979)
CYCLOPHOSPHAMIDE (1,689)
RITUXIMAB (1,588)
METHOTREXATE (1,401)
DOXORUBICIN (980)
VINCRISTINE (932)
PREDNISOLONE (873)
MYCOPHENOLATE MOFETIL (852)
DEXAMETHASONE (784)
Which FOSPHENYTOIN Alternatives Have Lower Disease recurrence Risk?
FOSPHENYTOIN vs FOSTAMATINIB
FOSPHENYTOIN vs FOSTEMSAVIR TROMETHAMINE
FOSPHENYTOIN vs FOTEMUSTINE
FOSPHENYTOIN vs FRAMYCETIN
FOSPHENYTOIN vs FREMANEZUMAB